一般医生对成年人失眠的评估和管理
Alexander Sweetman1, Cathy Andronis2, Kerry Hancock3
1PhD, Program Manager, Australasian Sleep Association, Adelaide, SA; Adelaide Institute for Sleep Health, Flinders Health and Medical Research Institute, Sleep Health, Flinders University, Adelaide, SA.
Australian journal of general practice
|October 3, 2023
概括
失眠认知行为疗法 (CBT-i) 是澳大利亚慢性失眠的推第一线治疗方法. 这种方法解决了失眠的根本原因,提供了持续的改善,并管理了诸如抑郁症等共同出现的疾病.
科学领域:
- 一般的做法一般的做法
- 睡眠医学 睡眠医学
- 心理学 心理学 心理学
背景情况:
- 睡眠障碍是澳大利亚全科医院常见的问题.
- 失眠严重影响日常功能,生活质量,增加抑郁风险.
- 失眠的认知行为疗法 (CBT-i) 是慢性失眠的第一线治疗方法.
研究的目的:
- 概述澳大利亚一般实践中基于证据的失眠评估和管理.
- 概述失眠患者的转诊选择.
- 为全科医生提供有关可用的治疗方法的信息.
主要方法:
- 审查目前的指导方针和治疗选择.
- 讨论CBT-i的传递方法.
- 专注于澳大利亚一般实践中的可访问性.
主要成果:
- 简要的失眠评估工具越来越多.
- 基于证据的治疗方法,包括CBT-i,越来越容易获得.
- CBT-i可以是自主指导的,也可以是受过培训的专业人士进行的.
结论:
- 澳大利亚的全科医生越来越多地获得有效的失眠治疗方法.
- CBT-i是一种得到良好支持的,对慢性失眠的第一线治疗方法.
- 可访问的CBT-i选项可以改善失眠和相关疾病的管理.
相关概念视频
Management of Insomnia
274
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
274
Insomnia
99
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
99
Sedatives and Hypnotics Drugs: Miscellaneous Agents
196
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
196
CNS Depressants: Barbiturates and Benzodiazepines
303
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
303
Sedatives and Hypnotics: Overview
428
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
428
Nightmares and Night Terrors
107
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
107


